3-氨基-3-(2-甲氧基苯基)丙酸 | 3334-66-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3-氨基-3-(2-甲氧基苯基)丙酸
• 英文名称: N-(2-carboxyethyl)-o-anisidine
• 英文别名: 3-(2-methoxyphenylamino)propionic acid；3-[(2-methoxyphenyl)amino]propanoic acid；3-(o-methoxyphenylamino)propionic acid；3-(2-Methoxy-anilino)-propionsaeure；β-(2-Methoxyanilino)-propionsaeure；N-(2-Methoxyphenyl)-β-alanin；3-(2-Methoxy-phenylamino)-propionic acid；3-(2-methoxyanilino)propanoic acid
• CAS: 3334-66-5
• 化学式: C₁₀H₁₃NO₃
• mdl: MFCD02720737
• 分子量: 195.218
• InChiKey: PQEUQSTVFNTQPB-UHFFFAOYSA-N

物化性质

• 溶解度：
  >29.3 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2922509090

反应信息

• 作为反应物：
  描述：

  3-氨基-3-(2-甲氧基苯基)丙酸 在 PPA 作用下， 以58%的产率得到5-甲氧基-2,3-二氢-4(1H)-喹啉酮
  参考文献：
  名称：

  通过喹诺酮类的施密特重排区域选择性合成四氢苯并二氮杂-5-酮

  摘要：

  摘要 2,3,4,5-四氢-1H-1,4-苯并二氮杂-5-酮通过C-氧取代基的1,2,3,4-四氢-4-喹诺酮类化合物的施密特重排进行区域选择性合成8 描述。

  DOI：

  10.1081/scc-200026212
• 作为产物：
  描述：

  methyl 3-[(2-methoxyphenyl)amino]propanoate 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 2.0h， 生成 3-氨基-3-(2-甲氧基苯基)丙酸
  参考文献：
  名称：

  通过喹诺酮类的施密特重排区域选择性合成四氢苯并二氮杂-5-酮

  摘要：

  摘要 2,3,4,5-四氢-1H-1,4-苯并二氮杂-5-酮通过C-氧取代基的1,2,3,4-四氢-4-喹诺酮类化合物的施密特重排进行区域选择性合成8 描述。

  DOI：

  10.1081/scc-200026212

文献信息

• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：HAPLOGEN GMBH

  公开号：WO2018050631A1

  公开（公告）日：2018-03-22

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

  本发明涉及一般式（I）的新化合物，其中X和R1至R4基团的含义如描述和索赔中所述，制备这些化合物的方法以及它们作为治疗、预防或改善病毒感染的用途，以及用于治疗、预防或改善与PLA2G16相关的疾病的用途。
• WRINKLE-IMPROVING AGENT
  申请人：Shiseido Company, Limited

  公开号：EP1941861A1

  公开（公告）日：2008-07-09

  The invention provides a novel wrinkle-improving agent that has an effect of improving wrinkles, that does not entail problems of safety or pain even when applied to the skin, and that contains a very safe substance as an active component. A discovery was made that N-benzoyl-β-alanine, other specific β-alanine derivatives, and salts thereof have a wrinkle-improving effect, whereby a wrinkle-improving agent containing as an active component one, two, or more types of compounds selected from the group composed of these specific β-alanine derivatives and the salts thereof was developed.

  该发明提供了一种新型的改善皱纹的剂，具有改善皱纹的效果，即使应用于皮肤也不会带来安全或疼痛问题，并且包含一种非常安全的物质作为活性成分。发现N-苯甲酰-β-丙氨酸、其他特定的β-丙氨酸衍生物及其盐具有改善皱纹的效果，因此开发了一种改善皱纹的剂，其活性成分包含从这些特定的β-丙氨酸衍生物及其盐组成的群体中选择的一种、两种或更多种化合物。
• Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin
  申请人：Kaminuma Mikiko

  公开号：US20120232111A1

  公开（公告）日：2012-09-13

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin—inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and further provides an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent comprises one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof. The external composition for skin comprises the one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent.

  本发明提供了一种角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂，具有诸如角化过度抑制、毛孔收缩或粗糙肌肤抑制/减轻等功能，不会引起感觉刺激等安全问题，非常安全，还提供了一种外用皮肤组成物，其中添加了具有上述功能的化合物。该角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂包括从β-丙氨酸衍生物和其盐的群组中选择的一种或多种化合物。该外用皮肤组成物包括上述β-丙氨酸衍生物和其盐中的一种或多种作为上述角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂。
• Aerobic Dehydrogenative Aromatization in the Preparation of 4-Aminoquinoline Derivatives by Synergistic Pd/Cu Catalysis
  作者：Fei Chen、Huidan Geng、Chun Li、Jianta Wang、Bing Guo、Lei Tang、Yuan-Yong Yang

  DOI：10.1021/acs.joc.3c01400

  日期：2023.11.17

  The 4-aminoquinoline moiety is widely present in various bioactive compounds and marketed drugs, while the preparation of this target structure relies heavily on the amination of 4-chloroquinolines. Herein, an atom and step economic procedure was developed based on an aerobic dehydrogenative aromatization strategy. Unlike the well-known palladium-catalyzed dehydrogenative aromatization of cyclohexanones

  4-氨基喹啉部分广泛存在于各种生物活性化合物和市售药物中，而该目标结构的制备很大程度上依赖于4-氯喹啉的胺化。在此，基于有氧脱氢芳构化策略开发了原子和步骤经济程序。与众所周知的钯催化环己酮与胺的脱氢芳构化不同，协同 Pd/Cu 催化对于 2,3-二氢喹啉-4(1 H )-one 类型的底物至关重要。在优化条件下，一系列芳香族/脂肪族胺和2,3-二氢喹啉-4(1H ) -酮偶联，以中等到高收率得到相应的4-氨基喹啉产物，并应用当前的方法还展示了上市药物的制备和后期多样化。
• PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN
  申请人：Shiseido Company, Limited

  公开号：EP1880711A1

  公开（公告）日：2008-01-23

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin -inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and further provides an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent comprises one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof. The external composition for skin comprises the one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent.

  本发明提供了一种角化抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂，它具有抑制角化、收缩毛孔或皮肤粗糙抑制/改善等功能，不会造成感官刺激等安全问题，而且非常安全，并进一步提供了一种添加了具有上述功能的化合物的皮肤外用组合物。角化抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂包括一种或多种选自 β-丙氨酸衍生物及其盐类的化合物。皮肤外用组合物包括选自由 β-丙氨酸衍生物及其盐组成的组的一种或多种化合物，作为上述角化病抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂。